It’s been a long time coming, but last week Ireland’s Minister for Health signed legislation to kick off a medical cannabis program in the country.
The program will operate on a pilot basis for five years and access will be restricted to patients with the following qualifying conditions.
- spasticity associated with MS (multiple sclerosis)
- intractable (not easily managed or controlled) nausea and vomiting
- sociated with chemotherapy
- severe, treatment-resistant epilepsy
It’s a pretty short list, but it’s a start.
Before medicines will be available, suppliers will need to apply to have their products assessed for suitability. Once medical cannabis products are available, specialist medical consultants will be able to prescribe them.
Read more at hempgazette.com
